FOXP3+ macrophage represses acute ischemic stroke-induced neural inflammation

Wei Cai1, Mengyan Hu1, Chunyi Li1

  • 1Department of Neurology, Mental and Neurological Disease Research Center, the Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.

Autophagy
|September 28, 2022
PubMed

Insights

FOXP3+ macrophages enhance tissue repair after acute ischemic stroke by improving debris clearance. Their activation is regulated by autophagy, offering a novel therapeutic target for stroke immunomodulation.

Area of Science:

  • Neuroscience
  • Immunology
  • Cell Biology

Background:

  • Proper resolution of inflammation is crucial for tissue repair following acute ischemic stroke (AIS).
  • Macrophages play a key role in clearing cellular debris and orchestrating immune responses post-stroke.

Purpose of the Study:

  • To investigate the role of FOXP3, typically found in regulatory T cells (Tregs), in macrophages during AIS.
  • To elucidate the mechanisms by which FOXP3 influences macrophage function and stroke outcomes.

Main Methods:

  • Conditional knockout of FOXP3 in macrophages in a mouse model of AIS.
  • Single-cell RNA sequencing (scRNAseq) and Cleavage Under Targets and Release Using Nuclease (CUT & RUN) to analyze FOXP3+ macrophages.
  • Investigation of the regulation of FOXP3 expression by macroautophagy and LC3-associated phagocytosis (LAP).

Main Results:

  • FOXP3 is conditionally expressed in macrophages within the stroke lesion, and its ablation worsens stroke outcomes.
  • FOXP3+ macrophages exhibit enhanced efferocytic capacity, distinct from M1 or M2 phenotypes, and facilitate phagocytosis via improved cargo metabolism.
  • FOXP3 activation is regulated by the interplay between macroautophagy and LAP, where LAP competitively inhibits autophagic degradation of FOXP3.

Conclusions:

  • FOXP3+ macrophages represent a distinct subset with potent scavenging capabilities, crucial for beneficial outcomes in AIS.
  • The findings highlight a novel mechanism controlling FOXP3 expression in macrophages through autophagic pathways.
  • Targeting FOXP3+ macrophages presents a promising immunomodulatory strategy for treating acute ischemic stroke.